Abstract
Some
N
‐tosylhydrazone derivatives were effectively synthesized under solvent‐free conditions by using a grinding method at room temperature. The short reaction time, clean and mild process with simple workup and easy purification of the target compounds were salient features of the present protocol, which enables straightforward access to
N
‐tosylhydrazones. Among the tosylhydrazone derivatives evaluated, compound
3 l
exhibits excellent apoptosis‐promoting and anticancer potential against triple‐negative breast cancer (TNBC) cell lines. This research shows that our synthesized compound
3 l
may be a desirable and effective therapeutic drug against TNBC.